SCHEMBL5490044

SCHEMBL5490044

Cc1ncc(NC(=O)c2cc(N3CCOCC3)cc(C(F)(F)F)c2)cc1C(=O)Nc1ccc(OCc2ccccn2)cc1

nearest known ligand 0.74

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.74
SMO Q99835 2/20 0.57
RAF1 P04049 14/20 0.52
BRAF P15056 14/20 0.52
CSF1R P07333 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4551884 0.94 MAPK14 (0.64) MAPK14SMORAF1BRAFCSF1R
SCHEMBL4551753 0.93 MAPK14 (0.64) MAPK14SMORAF1BRAFCSF1R
SCHEMBL4411010 0.91 MAPK14 (0.73) MAPK14SMO
SCHEMBL14534470 0.85 MAPK14 (0.67) MAPK14SMOBRAF
SCHEMBL4551883 0.85 MAPK14 (0.55) MAPK14SMOCSF1R
SCHEMBL4551752 0.84 MAPK14 (0.54) MAPK14SMO
SCHEMBL4551323 0.84 MAPK14 (0.72) MAPK14SMO
SCHEMBL4551331 0.83 MAPK14 (0.71) MAPK14SMO
SCHEMBL5481697 0.79 MAPK14 (0.71) MAPK14SMO
SCHEMBL5487782 0.79 RAF1 (0.57) RAF1BRAFCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112608617-B Triphenothiazinyl zinc porphyrin dye and preparation method thereof 桂林理工大学 2022-09-23 CN claimed
CN-112625461-B Phenoxazinyl zinc porphyrin dye and preparation method thereof 桂林理工大学 2022-09-20 CN claimed
CN-112625461-A Phenoxazinyl zinc porphyrin dye and preparation method thereof 桂林理工大学 2021-04-09 CN claimed
CN-112608617-A Triphenothiazinyl zinc porphyrin dye and preparation method thereof 桂林理工大学 2021-04-06 CN claimed
CN-112480705-A Double phenothiazinyl zinc porphyrin dye and preparation method thereof 桂林理工大学 2021-03-12 CN claimed
CN-115960098-A Preparation method and application of nitrogen-containing fused ring compounds 上海凌达生物医药有限公司 2023-04-14 CN disclosed
CN-113105382-B Biphenyl modified carbazole group anthracene-based deep blue light material and preparation and application thereof 华南理工大学 2023-03-21 CN disclosed
CN-115490836-A Electrochromic polymer capable of reversibly changing from yellow to high transmission and application thereof 浙江工业大学 2022-12-20 CN disclosed
CN-112608617-B Triphenothiazinyl zinc porphyrin dye and preparation method thereof 桂林理工大学 2022-09-23 CN disclosed
CN-112625461-B Phenoxazinyl zinc porphyrin dye and preparation method thereof 桂林理工大学 2022-09-20 CN disclosed
CN-112625461-A Phenoxazinyl zinc porphyrin dye and preparation method thereof 桂林理工大学 2021-04-09 CN disclosed
CN-112608617-A Triphenothiazinyl zinc porphyrin dye and preparation method thereof 桂林理工大学 2021-04-06 CN disclosed
CN-109020972-B Preparation method of triazolo [1,5-a ] quinoline derivative 广东石油化工学院 2021-03-09 CN disclosed
CN-108558948-B Diphospha-containing heterocyclic cyclopentadiene fused ring organic electroluminescent compound and synthesis method thereof 河南省科学院化学研究所有限公司 2020-04-07 CN disclosed
CN-108884035-B Substituted indoles as estrogen receptor down-modulators 罗欣药业(上海)有限公司 2020-03-13 CN disclosed
CN-110857300-A Condensed ring triazole compounds, preparation method and application 如东凌达生物医药科技有限公司 2020-03-03 CN disclosed
EP-3377592-A1 FLUORESCENT DYE FILMS FOR DETECTING NOX-BASED EXPLOSIVES IN THE AIR, IN SOLUTIONS, AND FROM WIPE SAMPLES Institut Dr. Foerster Gmbh & Co. Kg (DE) 2018-09-26 EP disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed
WO-2007056016-A2 BISAMIDE CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-05-18 WO disclosed
WO-2007056016-A2 BISAMIDE CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease ABAT, BPTF, TNNT2 MAPK14 3022/4885SMO 3508/4885RAF1 4140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.